IHC-plus(tm) RNF213 Antibody (aa5191-5204)

LifeSpan BioSciences

IHC-plus(tm) RNF213 Antibody (aa5191-5204)

23

Immunohistochemistry: LS-B1757 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B1757 was determined to be 1.25 ug/ml.. IHC, IHC-P (1.25 µg/ml), Peptide-ELISA (1:128000) Immunohistochemistry: LS-B1757 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B1757 was determined to be 1.25 ug/ml.

ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Unconjugated

RNF213

ring finger protein 213

ALO17, C17orf27, KIAA1618, MYMY2, MYSTR, NET57, E3 ubiquitin-protein ligase RNF213, protein ALO17, ALK lymphoma oligomerization partner on chromosome 17, E3 ubiquitin-lipopolysaccharide ligase RNF213, RING-type E3 ubiquitin transferase RNF213, mysterin

Goat

Human

-20°C

41116161